a School of Chinese Medicine, Hong Kong Baptist University , Hong Kong SAR , China.
b Mr. and Mrs. Ko Chi Ming Centre for Parkinson Disease Research, Hong Kong Baptist University , Hong Kong SAR , China.
Autophagy. 2017;13(11):1969-1980. doi: 10.1080/15548627.2017.1371393. Epub 2017 Oct 4.
Recent studies have demonstrated that dysregulation of macroautophagy/autophagy may play a central role in the pathogenesis of neurodegenerative disorders, and the induction of autophagy protects against the toxic insults of aggregate-prone proteins by enhancing their clearance. Thus, autophagy has become a promising therapeutic target against neurodegenerative diseases. In this study, quantitative phosphoproteomic profiling together with a computational analysis was performed to delineate the phosphorylation signaling networks regulated by 2 natural neuroprotective autophagy enhancers, corynoxine (Cory) and corynoxine B (Cory B). To identify key regulators, namely, protein kinases, we developed a novel network-based algorithm of in silico Kinome Activity Profiling (iKAP) to computationally infer potentially important protein kinases from phosphorylation networks. Using this algorithm, we observed that Cory or Cory B potentially regulated several kinases. We predicted and validated that Cory, but not Cory B, downregulated a well-documented autophagy kinase, RPS6KB1/p70S6K (ribosomal protein S6 kinase, polypeptide 1). We also discovered 2 kinases, MAP2K2/MEK2 (mitogen-activated protein kinase kinase 2) and PLK1 (polo-like kinase 1), to be potentially upregulated by Cory, whereas the siRNA-mediated knockdown of Map2k2 and Plk1 significantly inhibited Cory-induced autophagy. Furthermore, Cory promoted the clearance of Alzheimer disease-associated APP (amyloid β [A4] precursor protein) and Parkinson disease-associated SNCA/α-synuclein (synuclein, α) by enhancing autophagy, and these effects were dramatically diminished by the inhibition of the kinase activities of MAP2K2 and PLK1. As a whole, our study not only developed a powerful method for the identification of important regulators from the phosphoproteomic data but also identified the important role of MAP2K2 and PLK1 in neuronal autophagy.
最近的研究表明,宏观自噬/自噬的失调可能在神经退行性疾病的发病机制中发挥核心作用,自噬的诱导通过增强对聚集倾向蛋白的毒性刺激物的清除来保护免受其毒性损伤。因此,自噬已成为治疗神经退行性疾病的有希望的治疗靶点。在这项研究中,进行了定量磷酸化蛋白质组学分析和计算分析,以描绘 2 种天然神经保护自噬增强剂,柯诺辛(Cory)和柯诺辛 B(Cory B)调节的磷酸化信号网络。为了鉴定关键调节剂,即蛋白激酶,我们开发了一种新的基于网络的算法,即计算激酶活性分析(iKAP),从磷酸化网络中计算推断出潜在重要的蛋白激酶。使用该算法,我们观察到 Cory 或 Cory B 可能调节几种激酶。我们预测并验证了 Cory,但不是 Cory B,下调了一种有充分文献记载的自噬激酶,RPS6KB1/p70S6K(核糖体蛋白 S6 激酶,多肽 1)。我们还发现 2 种激酶,MAP2K2/MEK2(丝裂原激活蛋白激酶激酶 2)和 PLK1(丝氨酸/苏氨酸蛋白激酶 1),可能被 Cory 上调,而 MAP2K2 和 Plk1 的 siRNA 介导的敲低显著抑制了 Cory 诱导的自噬。此外,Cory 通过增强自噬促进阿尔茨海默病相关 APP(淀粉样β[A4]前体蛋白)和帕金森病相关 SNCA/α-突触核蛋白(突触核蛋白,α)的清除,而这些作用通过 MAP2K2 和 PLK1 的激酶活性抑制而显著减弱。总的来说,我们的研究不仅开发了一种从磷酸化蛋白质组学数据中鉴定重要调节剂的强大方法,而且还确定了 MAP2K2 和 PLK1 在神经元自噬中的重要作用。